Healthcare provider profile · identity verified

Leora Matian

Physician Assistant · ENCINO, CA · NPI 1205586468

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	146	37
Levothyroxine Sodium	Levothyroxine Sodium	143	34
Famotidine	Famotidine	132	35
Atorvastatin Calcium	Atorvastatin Calcium	122	35
Losartan Potassium	Losartan Potassium	102	19
Sertraline Hcl	Sertraline Hcl	102	21
Simvastatin	Simvastatin	93	23
Metformin Hcl	Metformin Hcl	85	21
Metoprolol Succinate	Metoprolol Succinate	78	20
Albuterol Sulfate Hfa	Albuterol Sulfate	76	28
Fluticasone Propionate	Fluticasone Propionate	72	35
Ozempic	Semaglutide	67	24
Vascepa	Icosapent Ethyl	65	16
Finasteride	Finasteride	64	19
Pantoprazole Sodium	Pantoprazole Sodium	64	22
Linzess	Linaclotide	61	16
Escitalopram Oxalate	Escitalopram Oxalate	60	16
Clonidine Hcl	Clonidine Hcl	57	14
Clopidogrel	Clopidogrel Bisulfate	57	11
Rosuvastatin Calcium	Rosuvastatin Calcium	57	21
Gabapentin	Gabapentin	56	16
Omeprazole	Omeprazole	55	24
Azithromycin	Azithromycin	53	48
Tamsulosin Hcl	Tamsulosin Hcl	51	12
Diclofenac Sodium	Diclofenac Sodium	47	23
Donepezil Hcl	Donepezil Hcl	46	11
Mounjaro	Tirzepatide	44	12
Furosemide	Furosemide	42	suppressed
Dexlansoprazole Dr	Dexlansoprazole	41	12
Gemtesa	Vibegron	41	17
Synthroid	Levothyroxine Sodium	40	suppressed
Icosapent Ethyl	Icosapent Ethyl	39	11
Jardiance	Empagliflozin	35	11
Triamcinolone Acetonide	Triamcinolone Acetonide	35	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	28
Montelukast Sodium	Montelukast Sodium	31	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	30	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	28	suppressed
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	23
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Atenolol	Atenolol	22	suppressed
Memantine Hcl	Memantine Hcl	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Ezetimibe	Ezetimibe	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Ibuprofen	Ibuprofen	19	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Methylprednisolone	Methylprednisolone	19	14
Carvedilol	Carvedilol	18	suppressed
Methimazole	Methimazole	18	suppressed
Prednisone	Prednisone	18	suppressed
Febuxostat	Febuxostat	17	suppressed
Bystolic	Nebivolol Hcl	16	suppressed
Eliquis	Apixaban	16	suppressed
Levofloxacin	Levofloxacin	16	13
Meclizine Hcl	Meclizine Hcl	16	11
Meloxicam	Meloxicam	16	suppressed
Rexulti	Brexpiprazole	16	suppressed
Trazodone Hcl	Trazodone Hcl	16	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	15	suppressed
Lisinopril	Lisinopril	15	suppressed
Restasis	Cyclosporine	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	13	suppressed
Baclofen	Baclofen	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Estradiol	Estradiol	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Naproxen	Naproxen	12	suppressed
Procto-Med Hc	Hydrocortisone	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error